TBS-1 intranasal

TBS-1 · Acerus Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TBS-1 intranasal, covering 2018-06-13 to 2018-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism [Phase 3]